Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
849.50    -28.50 (-3.25%)
Bid:
852.50
Ask:
854.50
Spread: 2.00 (0.235%)
Market Cap: £978.40m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Kainos Director/PDMR Shareholding

4 Jul 2018 16:51

RNS Number : 6382T
Kainos Group plc
04 July 2018
 

4 July 2018

 

Kainos Group plc

 

("Kainos" or the "Company)

Director / PDMR shareholdings

The Company announces that on 4 July 2018, share awards (the "Awards") approved by the Board of Directors of the Company under:

(i) the Kainos Group Performance Share Plan (the "PSP Awards"), in the form of nominal value options over Ordinary Shares were awarded to executive directors and executive managers of the Company. The PSP Awards vest, other than in exceptional circumstances, over a three year period from 4 July 2018. The performance conditions associated with the PSP Awards are as follows:

 

(a) 50% of each PSP Award is subject to a performance condition based on the Company's Earnings Per Share ("EPS") Growth measured over the three financial years commencing 1 April 2018. This portion of the PSP Award will:

· not vest at all if EPS Growth over the measurement period is less than 9%;

· vest in respect of 30% if EPS Growth over the measurement period is 9%;

· vest in full if EPS Growth over the measurement period is 16% or higher;

· vest proportionately, calculated on a straight line basis if EPS Growth over the measurement period is higher than 9% but less than 16%.

 

(b) 50% of each PSP Award is subject to a performance condition based on the Company's Total Shareholder Return ("TSR") Growth per ordinary share measured over the period of three years commencing 4 July 2018. This portion of the PSP Award will:

· not vest at all if TSR Growth over the measurement period is less than 9%;

· vest in respect of 30% if TSR Growth over the measurement period is 9%;

· vest in full if TSR Growth over the measurement period is 16% or higher;

· vest proportionately, calculated on a straight line basis if TSR Growth over the measurement period is higher than 9% but less than 16%.

 

 

(ii) Kainos Group plc SAYE Plan (the "SAYE Awards"), in the form of options at 20% discount to market value were awarded to all staff including executive directors and executive managers of the Company.

 

 

 

 

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them.

 (A19 Market Abuse Regulation)

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Brendan Mooney

2.

Reason for the notification

a.

Position/status

CEO

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Options over Ordinary Shares of £0.005 each

 

KNOS

b.

Nature of the transaction

PSP Share Awards 2018

c.

Price(s) and volume(s)

 

PSP Award

Exercise Price(s)

Volume(s)

£0.005

17,621

 

 

d.

Aggregated information

· Aggregated volume

· Price

 

N/A

e.

Date of the transaction

2018-07-04

f.

Place of the transaction

Outside a trading venue

 

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Richard McCann

2.

Reason for the notification

a.

Position/status

CFO/COO

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Options over Ordinary Shares of £0.005 each

 

KNOS

b.

Nature of the transaction

PSP and SAYE Share Awards 2018

c.

Price(s) and volume(s)

SAYE Award1

Exercise Price(s)

Volume(s)

£3.3627

1,070

 

PSP Award2

Exercise Price(s)

Volume(s)

£0.005

19,552

 

1. Subject to a 3 year vesting period other than in exceptional circumstances.

2. Subject to the PSP Awards vesting criteria.

 

d.

Aggregated information

· Aggregated volume

· Price

 

N/A

e.

Date of the transaction

2018-07-04

f.

Place of the transaction

Outside a trading venue

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Paul Gannon

2.

Reason for the notification

a.

Position/status

Sales Director

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Options over Ordinary Shares of £0.005 each

 

KNOS

b.

Nature of the transaction

PSP and SAYE Share Awards 2018

c.

Price(s) and volume(s)

Options Award (equivalent to UK SAYE)1, 2

Exercise Price(s)

Volume(s)

£3.3627

1,070

 

PSP Award3

Exercise Price(s)

Volume(s)

£0.005

15,690

 

1. Subject to 3 year vesting period other than in exceptional circumstances.

2. Mr Gannon's option awards are under an unapproved option scheme in Republic of Ireland to replicate SAYE awards to U.K. staff.

3. Subject to the PSP Awards vesting criteria.

d.

Aggregated information

· Aggregated volume

· Price

 

N/A

e.

Date of the transaction

2018-07-04

f.

Place of the transaction

Outside a Trading Venue

 

Ends

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

 

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc +44 20 7597 5970

 

Patrick Robb / Sebastian Lawrence

 

Canaccord Genuity +44 20 7523 4606

 

Simon Bridges / Emma Gabriel

 

FTI Consulting LLP +44 20 3727 1000

 

Matt Dixon / Jamie Ricketts

 

 

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers; and Smart is an automated testing platform for Workday customers.

Kainos has over 1,150 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEASXLELNPEFF
Date   Source Headline
4th Jun 202611:31 amRNSDirector / PDMR shareholdings
1st Jun 202610:27 amRNSTotal Voting Rights
18th May 20267:00 amRNSFull Year Results
18th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 202611:06 amRNSTotal Voting Rights
28th Apr 20261:38 pmRNSBoard and Board Committee Changes
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSYear-end Trading Update
14th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:22 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20265:10 pmRNSDirector Declaration
24th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20263:16 pmRNSNotification of Major Holdings
17th Mar 202611:28 amRNSDirector/PDMR shareholdings
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20264:58 pmRNSNotification of Transactions of Director/PDMR
12th Mar 20262:13 pmRNSHolding(s) in Company
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:30 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20269:43 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.